CHMP1A and Crohn disease: Remarkably, there was no difference in mRNA expression of ED-A or PCOLN3 in biopsies from Crohn’s disease patients who responded endoscopically to IFX treatment, compared to their own biopsies right before IFX treatment (Fig 6).